MICROBIOME THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECAS

Author : coherent mii | Published On : 22 Apr 2026

The global microbiome therapeutics market is expected to grow from USD 57.4 Mn in 2026 to USD 310.6 Mn by 2033, registering a compound annual growth rate (CAGR) of 27.3%. The market for microbiome therapeutics is poised for significant expansion, fueled by rising global burden of antimicrobial resistance (AMR).

A study in The Lancet reports that antimicrobial resistance (AMR) was linked to an estimated 4.71 million deaths around the world in 2021, out of which 1.14 million have been caused by antimicrobial resistance (AMR) directly. Estimates suggest that deaths from antimicrobial resistance (AMR) will increase to nearly 1.91 million per year by 2050, with total deaths being around 8.22 million

https://www.coherentmarketinsights.com/industry-reports/microbiome-therapeutics-market